AEOLUS PHARMACEUTICALS, INC. 4
4 · AEOLUS PHARMACEUTICALS, INC. · Filed Feb 3, 2016
Insider Transaction Report
Form 4
Kaye Mitchell D
Director
Transactions
- Award
Non-qualified Stock Option (right to buy)
2013-10-01+75,000→ 75,000 totalExercise: $0.26Exp: 2023-10-01→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.